Dogwood Therapeutics, Inc. (DWTX): Shareholders' Equity
$74.90M
As of 2025-12-31
$68.37M
As of 2026-06-30
+117.0%
3-year compound annual growth
+20.1%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $74.90M | n/m | 2026-03-18, Balance as of period end |
| 2024-12-31 | -$10.12M | n/m | 2026-03-18, Balance as of period end |
| 2023-12-31 | $3.81M | -48.0% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $7.33M | -49.5% | 2024-03-08, Balance as of period end |
| 2021-12-31 | $14.50M | -51.6% | 2023-03-14, Balance as of period end |
| 2020-12-31 | $29.94M | n/a | 2022-03-18, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | 2025-12-31 | $74.90M | n/m |
| vTv Therapeutics Inc. (VTVT) | 2025-12-31 | $64.44M | +428.2% |
| Shattuck Labs, Inc. (STTK) | 2025-12-31 | $82.39M | +3.5% |
| Pyxis Oncology, Inc. (PYXS) | 2025-12-31 | $53.41M | -55.8% |
| Eton Pharmaceuticals, Inc. (ETON) | 2025-12-31 | $26.15M | +7.1% |
| Relmada Therapeutics, Inc. (RLMD) | 2025-12-31 | $86.51M | +143.5% |
| Eupraxia Pharmaceuticals Inc. (EPRX) | 2025-12-31 | $82.04M | +145.6% |
| Journey Medical Corp (DERM) | 2025-12-31 | $31.85M | +58.7% |
| Arbutus Biopharma Corp (ABUS) | 2025-12-31 | $76.58M | -21.4% |
Compare DWTX, VTVT, STTK, PYXS side by side · Screen every company in Pharmaceutical Preparations ↗